[December 12, 2017] |
|
U.S. Synthroid Promotional Report 2016-2017 - Research and Markets
The "Synthroid
2016 U.S Promotional Report" report has been added to Research
and Markets' offering.
The 5 Key Questions Addressed by this Report:
-
How many physicians were reached by Synthroid through personal
promotion in 2016 and how does this compare to its peer set in the
Hypothyroidism and Pituitary TSH Suppression markets?
-
What promotional mix was leveraged (e.g., sales rep detailing,
physician education, and paid speaking) and what was the median spend
on each type of activity?
-
How does AbbVie's depth of coverage vary within key specialties (e.g.,
Family Medicine, Internal Medicine, and Endocrinology) and how does
this compare to its eers and the overall set of rep-accessible
physicians?
-
How often are physicians receiving paid meals for Synthroid throughout
the year (e.g., monthly, quarterly, annually)?
-
Who were the most detailed prescribers and top paid speakers for
Synthroid in 2016?
Data Sources and Methodology:
-
We leverage company-reported financial transaction data disclosed
through CMS Open Payments. This data set captures all transfers of
value (e.g., speaking fees, consulting fees, travel, education, and
meals) made on behalf of a drug or device manufacturer to a physician.
Currently, 42 months of longitudinal data is available - covering
payments to more than 900,000 U.S. healthcare professionals.
-
Over 35,500 paid interactions across 12,900 physicians made on behalf
of Synthroid were carefully examined to support our analysis. In
addition, interaction data from 1 peer products (e.g. Unithroid) was
leveraged to provide benchmarking and market insights.
For more information about this report visit https://www.researchandmarkets.com/research/pd2pgn/u_s_synthroid?w=4
View source version on businesswire.com: http://www.businesswire.com/news/home/20171212006161/en/
[ Back To TMCnet.com's Homepage ]
|